Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 16 AL 30

Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies

Avila J, Pallas N, Bolós M, Sayas CL, Hernandez F.

Expert Opin Ther Targets. 2016 Jun;20(6):653-61. doi: 10.1517/14728222.2016.1131269. Epub 2016 Feb 16.

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease

Bu XL, Jiao SS, Lian Y, Wang YJ.

Curr Alzheimer Res. 2016;13(3):307-16. doi: 10.2174/1567205013666151215110114.

Home Modifications for People With Alzheimer's Disease: A Scoping Review

Struckmeyer LR, Pickens ND.

Am J Occup Ther. 2016 Jan-Feb;70(1):7001270020p1-9. doi: 10.5014/ajot.2015.016089.

[Pharmacotherapy and dementia]

Drobizhev MY, Fedotova AV, Kikta SV, Antokhin EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10):110-116. doi: 10.17116/jnevro2016116101110-116.

Medicinal Chemistry Focusing on Aggregation of Amyloid-β

Sohma Y.

Chem Pharm Bull (Tokyo). 2016;64(1):1-7. doi: 10.1248/cpb.c15-00742.

Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type

Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, König A, Robert P.

J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.

Tau Biology and Tau-Directed Therapies for Alzheimer's Disease

Bakota L, Brandt R.

Drugs. 2016 Mar;76(3):301-13. doi: 10.1007/s40265-015-0529-0.

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik C, Hof PR.

Biomolecules. 2016 Jan 6;6(1):6. doi: 10.3390/biom6010006.

The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?

Song C, Shieh CH, Wu YS, Kalueff A, Gaikwad S, Su KP.

Prog Lipid Res. 2016 Apr;62:41-54. doi: 10.1016/j.plipres.2015.12.003. Epub 2016 Jan 4.

Can cloud-based tools accelerate Alzheimer's disease drug discovery?

Cacabelos R, Teijido O, Carril JC.

Expert Opin Drug Discov. 2016;11(3):215-23. doi: 10.1517/17460441.2016.1141892. Epub 2016 Feb 3.

Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: protocol for a systematic review and individual patient data network meta-analysis

Veroniki AA, Straus SE, Ashoor HM, Hamid JS, Hemmelgarn BR, Holroyd-Leduc J, Majumdar SR, McAuley G, Tricco AC.

BMJ Open. 2016 Jan 13;6(1):e010251. doi: 10.1136/bmjopen-2015-010251.

Red Raspberries and Their Bioactive Polyphenols: Cardiometabolic and Neuronal Health Links

Burton-Freeman BM, Sandhu AK, Edirisinghe I.

Adv Nutr. 2016 Jan 15;7(1):44-65. doi: 10.3945/an.115.009639. Print 2016 Jan.

Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease

Echeverria V, Yarkov A, Aliev G.

Prog Neurobiol. 2016 Sep;144:142-57. doi: 10.1016/j.pneurobio.2016.01.002. Epub 2016 Jan 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias